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Charles Russell4, Joanna Houghton1, Christine Palmer1, Martin J. Holland1,  
Richard T. Le Mesurier5, Anthony W. Solomon1, David C. W. Mabey1  
and Chrissy h. Roberts1
1 Clinical Research Department, London School of Hygiene & Tropical Medicine, London, United Kingdom, 2 Eye Department, 
Ministry of Health and Medical Services, Honiara, Solomon Islands, 3 Primary Care Department, Lata Hospital, Santa Cruz 
Island, Solomon Islands, 4 Bellona Rural Health Centre, Bellona, Solomon Islands, 5 The Fred Hollows Foundation, Carlton, 
VIC, Australia
Background: Several non-chlamydial microbial pathogens are associated with clinical 
signs of active trachoma in trachoma-endemic communities with a low prevalence of 
ocular Chlamydia trachomatis (Ct) infection. In the Solomon Islands, the prevalence of 
Ct among children is low despite the prevalence of active trachoma being moderate. 
Therefore, we set out to investigate whether active trachoma was associated with a 
common non-chlamydial infection or with a dominant polymicrobial community dysbio-
sis in the Solomon Islands.
Methods: We studied DNA from conjunctival swabs collected from 257 Solomon 
Islanders with active trachoma and matched controls. Droplet digital PCR was used to 
test for pathogens suspected to be able to induce follicular conjunctivitis. Polymicrobial 
community diversity and composition were studied by sequencing of hypervariable 
regions of the 16S ribosomal ribonucleic acid gene in a subset of 54 cases and 53 
controls.
results: Although Ct was associated with active trachoma, the number of infections 
was low (cases, 3.9%; controls, 0.4%). Estimated prevalence (cases and controls, 
respectively) of each non-chlamydial infection was as follows: Staphylococcus aureus: 
1.9 and 1.9%, Adenoviridae: 1.2 and 1.2%, coagulase-negative Staphylococcus: 5.8 
and 4.3%, Haemophilus influenzae: 7.4 and 11.7%, Moraxella catarrhalis: 2.3 and 4.7%, 
and Streptococcus pneumoniae: 7.0 and 6.2%. There was no statistically significant 
association between the clinical signs of trachoma and the presence or load of any 
of the non-Ct infections that were assayed. Interindividual variations in the conjunc-
tival microbiome were characterized by differences in the levels of Corynebacterium, 
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Propionibacterium, Helicobacter, and Paracoccus, but diversity and relative abundance 
of these specific genera did not differ significantly between cases and controls.
Discussion: It is unlikely that the prevalent trachoma-like follicular conjunctivitis in this 
region of the Solomon Islands has a dominant bacterial etiology. Before implementing 
community-wide azithromycin distribution for trachoma, policy makers should consider 
that clinical signs of trachoma can be observed in the absence of any detectable 
azithromycin-susceptible organism.
Keywords: droplet digital Pcr, solomon islands, 16s rrna gene sequencing, trachoma, non-chlamydial infections
inTrODUcTiOn
Trachoma, caused by Chlamydia trachomatis (Ct), is the lead-
ing infectious cause of preventable blindness (1) and is targeted 
for elimination as a public health problem by 2020 through 
the SAFE strategy (Surgery, Antibiotics, Facial cleanliness 
and Environmental improvement). The decision to imple-
ment community-wide trachoma control interventions, which 
include mass drug administration (MDA) with azithromycin, 
is based on population prevalence estimates of one clinical 
sign of active trachoma [trachomatous inflammation–follicular 
(TF)] in the 1- to 9-year-old age group (2). In the Solomon 
Islands, the prevalence of TF is sufficient to warrant MDA, but 
the prevalence of trachomatous trichiasis (TT) suggests that 
trachoma may not pose a significant public health problem. 
A recent trachoma survey in a treatment-naive population of 
the Solomon Islands estimated 26% of 1 to 9 year olds to have 
TF, but, surprisingly, conjunctival Ct infection was detected 
in only 1.3% of that age group (3). While Ct infection is not 
always detectable in TF cases (4, 5), infection prevalence in the 
Solomon Islands is far lower than is seen in other countries with 
similar TF prevalence (3).
Chlamydia trachomatis is not the only pathogen to associate 
with signs of TF. A number of differential diagnoses for follicular 
conjunctivitis are described (6), some of which are rare and dis-
tinguishable by patient history (such as Parinaud’s oculoglandu-
lar syndrome). Other causes of conjunctivitis, which can present 
with follicles, are Streptococcus pneumoniae, Haemophilus influ-
enzae (7), and adenovirus (8). Non-ocular Chlamydia serotypes 
(9) and non-Ct species (10) have also been suggested as possible 
causes of TF. A number of studies have examined conjunctival 
microbiology in trachoma-endemic areas. A greater diversity 
of pathogens can be cultured from the conjunctivae of people 
with TF compared to counterparts without TF (7). Among 
bacterial species isolated during a study in Tanzanian children, 
S. pneumoniae, H. influenzae B, and H. influenzae non-type B 
associated more strongly than Ct with clinical signs of active 
trachoma (7). In The Gambia, S. pneumoniae and H. influenzae 
type B infection correlated closely with signs of active trachoma 
in communities that had previously received MDA, whereas 
Moraxella catarrhalis and Staphylococcus aureus did not (11). 
Common non-chlamydial pathogens have associated with tra-
chomatous scarring (TS) (12) and recurrence of TT after surgery 
(13) in some, but not all (13, 14), studies.
Although traditionally thought to be “sterile”, several studies 
have now described polymicrobial communities colonizing the 
conjunctival epithelium (15, 16). Staphylococcus, Streptococcus, 
Haemophilus, and Moraxella genera can be readily cultured from 
swabs taken from the inferior fornix (7, 11, 12). Attempts to detect 
bacteria from the conjunctiva have shown community diversity 
and composition to vary significantly between individuals. It is 
unclear whether a “core” microbiota persists at the conjunctiva, 
but profiles closely related to that of the skin have been reported 
(17). Corynebacterium, Propionibacterium, Staphylococcus, and 
Streptococcus have been consistently dominant, whereas other 
genera such as Acinetobacter, Brevundimonas, Pseudomonas, 
Bradyrhizobium, Sphingomonas, Bacillus, Simonsiella, and 
Elizabethkingia have been identified more sporadically (18–20). 
Conjunctival polymicrobial community composition is known 
to vary with age and season (21) and appears to be responsive 
to external stimuli such as regular contact lens wear (22). The 
conjunctival microbiome varies significantly between people 
with TS and those without; however, significant associations 
between microbiome and follicular conjunctival inflammation or 
microbiome and other diseases have yet to be described (21, 23).
We hypothesized that clinical signs of active trachoma in 
the Solomon Islands where ocular Ct is uncommon could be 
explained by a common non-chlamydial infection or by a domi-
nant polymicrobial community dysbiosis.
MaTerials anD MeThODs
study ethics
A parent or guardian gave written informed consent for each 
child to take part in the survey in accordance with the Declaration 
of Helsinki. The protocol was approved by the London School 
of Hygiene & Tropical Medicine (6319/6360) and the Solomon 
Islands National Health Research (HRC13/18) Ethics Committees.
study Population
The samples tested during this study were a subset of specimens 
from a population-based trachoma prevalence survey of 3,674 
people (1,135 children aged 1–9  years) in 32 clusters from 
Temotu and Rennell & Bellona Provinces, Solomon Islands; 
data from that survey are presented elsewhere (3). At the time 
of the survey, no trachoma interventions had been implemented 
in the Solomon Islands. Sterile swabs were passed three times 
TaBle 1 | Oligonucleotides used in this study, with assay concentrations derived from in vitro optimization.
Organism/target Oligo sequence (5′-3′) concentration in 
final assay (nM)
amplicon 
size
reference
Chlamydia trachomatis/plasmid open 
reading frame 2 (pORF2)
F CAG CTT GTA GTC CTG CTT GAG AGA 900 109 (3, 25, 33)
R CAA GAG TAC ATC GGT CAA CGA AGA 900
Probe [FAM] CCC CAC CAT TTT TCC GGA GCG A [BHQ1] 200
Staphylococcus aureus/Staphylococcal 
protein A (SpA)
F CAG CAA ACC ATG CAG ATG CTA 900 101 (31, 32)
R CGC TAA TGA TAA TCC ACC AAA TAC A 900
Probe [VIC] TCA AGC ATT ACC AGA AAC [MGBNFQ] 250
Coagulase-negative Staphylococcus/
translation elongation factor (tuf)
F TAT CCA CGA AAC TTC TAA AAC AAC TGT TAC T 450 204 (32)
R TCT TTA GAT AAT ACG TAT ACT TCA GCT TTG AAT TT 450
Probe [FAM] TAT TAG ACT ACG CTG AAG CTG GTG ACA ACA T [BHQ1] 125
Streptococcus pneumoniae/N-
acetylmuramoyl-l-alanine amidase (lytA)
F ACG CAA TCT AGC AGA TGA AGC A 500 75 (27)
R TCG TGC GTT TTA ATT CCA GCT 500
Probe [FAM] GCC GAA AAC GCT TGA TAC AGG GAG [BHQ1] 150
Haemophilus influenzae/l-fuculokinase
(fucK)b
F ATG GCG GGA ACA TCA ATG A 900 102 (28)
R ACG CAT AGG AGG GAA ATG GTT 900
Probea [FAM] CGg TAa TTg GGa TCc AT [BHQ1] 125
Adenoviridae/capsid assembly protein 
(hexon)
F GCC ACG GTG GGG TTT CTA AAC TT 500 132 (26)
R GCC CCA GTG GTC TTA CAT GCA CAT C 500
Probe [HEX] TGC ACC AGA CCC GGG CTC AGG TAC TCC GA [BHQ1] 125
Moraxella catarrhalis/outer membrane 
protein (copB)
F GTG AGT GCC GCT TTT ACA ACC 900 72 (29, 30)
R TGT ATC GCC TGC CAA GAC AA 900
Probe [HEX] TGC TTT TGC AGC TGT TAG CCA GCC TAA [BHQ1] 250
aLower case symbols denote locked nucleic acid bases.
bThese primers do not differentiate between encapsulated and non-capsulated subtype.
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over the right conjunctiva of every child before storage in 300 µL 
RNALater® (Life Technologies). Swabs were kept cool in the field 
for up to 48 h then frozen until processing (3). Inclusion criteria 
for cases (n = 257) were age 1–9 years, detectable human DNA 
in the conjunctival swab, and a field grade of TF or trachomatous 
inflammation—intense (TI) in the right eye. An equal number 
(n = 257) of age-, gender- and island-matched controls without TF 
or TI were selected using the “e1071” R package. A random subset 
of cases (n = 54) and controls (n = 53) were further characterized 
using V1–V3 16S ribosomal RNA (rRNA) gene sequencing. Field 
controls (clean swabs passed within 20 cm of seated participants, 
without touching them, and then treated identically to subjects’ 
specimens), extraction controls (extraction carried out in the 
absence of a specimen and PCR carried out on the eluate), and 
PCR controls (PCR carried out in the absence of any added 
material) were used to determine background levels of microbial 
contamination in the 16S rRNA gene sequencing protocol.
Droplet Digital Pcr
DNA was extracted from conjunctival swabs using the Qiagen 
AllPrep DNA/RNA kit. We chose not to use mechanical lysis on 
these low biomass specimens due to the reported lower yields 
compared to chemical lysis (24). All specimens have previously 
been tested for Ct and Homo sapiens ribonuclease P protein 
subunit p30 (acting as an endogenous control) using a validated 
assay (25); the community prevalence of ocular Ct infection is 
described elsewhere (3).
Duplex ddPCR assays were developed for (1) Adenoviridae (26) 
and S. pneumoniae (2, 27), H. influenzae (28) and M. catarrhalis (29, 
30), and S. aureus and coagulase-negative Staphylococcus (31, 32) 
based on the published assays. Each assay contained 10 µL 2× 
ddPCR Supermix for probes (Bio-rad, Hemel Hempstead, UK), 
primers and probes at custom concentrations (Table  1), and 
8 µL of template DNA. Thermal cycling was performed for 10 
mins at 95°C, 40 cycles of 15 seconds at 95°C then 1  min at 
60°C, followed by 12 minutes at 98°C. A positive result for a 
clinical specimen was defined as >95% confidence of non-zero 
target load, as described previously (25). Assay performance was 
assessed by repeat testing of PCR product dilution series’ and 
cultured pathogen material before rolling out to clinical samples. 
The reproducibility, linearity, and limits of detection of each 
assay were considered appropriate (Table S1 in Supplementary 
Material) and were also similar to published performance of the 
Ct assay used (25).
16s rrna gene sequencing
An approximately 530-bp region of the 16S rRNA gene (vari-
able regions 1–3) was amplified using forward (modified 27F; 
5′-[adaptor]-AGAGTTTGGATCCTGGCTCAG-3′) and custom 
barcoded reverse primers (534R; 5′-[adaptor]-[barcode]-
AGTCAGTCAGCCATTACCGCGGCTGCTGG-3′). Each 15 µL 
reaction contained 7.5 µL 2× Phusion High Fidelity Master Mix 
(New England Biosciences, MA, USA), 0.45 µL DMSO, 0.1 µM 
primers, and 5.55  µL DNA. The thermal cycling conditions 
were as follows: 30 seconds at 98°C followed by 31 cycles of 
10 seconds at 98°C then 30 seconds at 62°C followed by 7 min-
utes at 72°C. Amplicons were cleaned using 0.6  v/v AMPure 
XP beads (Beckman Coulter, CA, USA), quantified using 
Qubit (Thermo Fisher Scientific, MA, USA), and then pooled 
at equimolar concentrations. The 4-nM sequencing library was 
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mixed 0.75  v/v with a 4  nM Phi-X control library (Illumina, 
CA, USA). 3  µL of 100  µM custom read primers were mixed 
into wells 12 (Read 1; CTACACTATGGTAATTGTAGAGT 
TTGGATCCTGGCTCAG), 13 (Index; CCAGCAGCCGCGGTA 
ATGGCTGACTGACT), and 14 (Read 2; AGTCAGTCAGCCAT 
TACCGCGGCTGCTGG) of the MiSeq reagents cartridge before 
2 × 300 bp paired-end sequencing with the 600-cycle MiSeq v3 
sequencing reagent kit on the MiSeq platform using a standard 
Illumina protocol. 96 uniquely barcoded specimens were run in 
multiplex on each MiSeq run.
Data analysis
ddPCR data were analyzed using R version 3.2.2 (34). Binomial 
univariate regression was used to test the relationship between 
each individual infection and active trachoma. The most accu-
rate final multivariate model, determined by the lowest Akaike 
Information Criterion value, was determined by stepwise 
removal of variables from a binomial multivariate regression 
model incorporating all tested pathogens. The chance of the Ct 
association occurring due to chance was assessed by counting the 
number of significant results obtained from randomly reordering 
the Ct data 1,000 times.
Raw 16S amplicon sequences were directly assigned to genera 
using Illumina BaseSpace “16S Metagenomics” app version 
1.0.1.0, which uses algorithms from Wang et al. (35). Two clini-
cal specimens yielded fewer than 1,000 reads in total and were 
removed from the analysis. Amplicons were sequenced from six 
no-template control (NTC) specimens (two “field” controls, two 
“extraction” controls, and two “PCR” controls, defined above) to 
identify any contaminants endogenous to the collection, PCR, or 
sequencing process. Any genera represented by more than 600 
reads in the 6 combined NTCs (average 100 reads per NTC) were 
eliminated from the clinical specimen analysis. This resulted in 
the removal of 21 genera, which accounted for 95.1% of the reads 
from NTCs and 88.3% of the reads from clinical specimens. The 
genera removed included common contaminants of reagent kits 
(36) such as Pelomonas, as well as some previously described 
conjunctival microbiota constituents such as Brevundimonas, 
Staphylococcus, and Streptococcus (18, 21).
Between-group differences in the Shannon Diversity Index 
(a measure of diversity, which increases with increasing species 
abundance and evenness) and Inverse Simpson Index (another 
measure of diversity where 1 is infinite diversity and 0 is no 
diversity) were compared using a t-test. Discriminant analysis 
of principal components, a multivariate clustering method to 
analyze highly dimensional datasets, was performed using the 
“adegenet” package in R (37), and cross-validation was used to 
determine the optimal number of principal components (PCs) 
to include in a discriminant function aimed at separating cases 
from controls on the basis of their polymicrobial community 
structures.
resUlTs
specimen set Demographics
A total of 257 cases and 257 controls (n =  514) were tested. 
All 257 cases had TF, and one also had TI. Case status was 
defined by clinical signs in the right eye, but 236/257 (91.8%) 
and 8/257 (3.1%) of the cases and controls, respectively, had 
TF in the left eye. Both case and control groups were 38% 
female. Mean age was 5.6 years (cases) and 5.5 years (controls; 
Student’s t-test p = 0.76). There was no significant difference 
between cases and controls in terms of the clusters represented 
(Kolmogorov–Smirnov test p = 0.97), and all 32 clusters were 
represented. The case specimens had higher loads of human 
DNA than the controls (18,030 versus 9,354 copies/swab; 
p  =  0.00003). There were no significant differences in age, 
gender, or location within the subset selected for 16S-amplicon 
sequencing.
Quantitative Pcr Tests for Ocular 
Pathogens
In this study, 19.8% of children had evidence of infection with 
at least one of the targeted organisms (Table 2). We considered 
the prevalence of Ct in this sample set to be too low (96.1% of 
TF cases were Ct infection negative) to account for the level of 
active disease. The prevalence of both Adenoviridae (1.2%) and S. 
aureus (1.9%) were very low. There was no association between 
active trachoma and infection with H. influenzae, S. pneumoniae, 
S. aureus, coagulase-negative Staphylococcus, or M. catarrhalis. 
Ct infection was associated with active trachoma (logistic regres-
sion p = 0.026; odds ratio, 10.4). The association between Ct and 
active trachoma was still significant in a multivariate analysis 
(p = 0.025). The permuted p value for the association between 
Ct and active trachoma was highly significant (p = 0.001). Active 
disease was neither associated with infection with at least one 
pathogen (any pathogen, p = 0.185) nor the number of concur-
rent infections in the same eye (number of concurrent pathogens, 
p = 0.207). Infection loads of those who tested positive are shown 
in Figure 1. Despite some numerical differences between groups, 
none of the differences were statistically significant.
16s rrna gene sequencing
The total number of genera identified across all clinical specimens 
and NTCs was 659; however, 125/659 (19%) had a cumulative 
total of 10 reads or fewer. The median number of reads per clinical 
specimen was 55,104 (interquartile range [IQR]: 40,705–89,541), 
and the median percentage of reads mapped to genus level was 
51.9%. The median number of genera identified was 151 (IQR: 
117–212) per clinical specimen. After the removal of presumed 
contaminants, approximately 40% of cleaned reads were assigned 
to genera that each constituted less than 1% of the total polymi-
crobial community. 34 genera were represented by at least 1% of 
remaining reads in clinical samples.
The diversity of bacterial communities was in general low; the 
mean Inverse Simpsons Diversity index over all specimens was 
0.061 (IQR: 0.046–0.092). The median Inverse Simpson’s Diversity 
index in cases was 0.061 (IQR: 0.048–0.095) versus controls 
0.060 (IQR: 0.044–0.078) (Student’s t-test p = 0.56). The median 
Shannon Diversity Index was 3.38 in cases and 3.37 in controls 
(Student’s t-test p = 0.96). There was no significant difference in 
alpha-diversity between cases and controls by either measure 
of diversity. In cases of active trachoma, the most dominant 
FigUre 1 | Target copies per swab of each pathogen identified in conjunctival swabs collected from children with and without active trachoma in the Solomon 
Islands. Numbers show p values for logistic regression comparison between active trachoma case and control groups for each pathogen. None of the differences 
observed were statistically significant. TF, trachomatous inflammation–follicular; TI, trachomatous inflammation—intense.
TaBle 2 | Cases of infection in specimens from children with and without active disease.
Pathogen ddPcr result no TF/Ti (%; 
n = 257)
TF/Ti (%;  
n = 257)
Total (%;  
n = 514)
Univariate odds ratio 
(95% ci)
Univariate 
(p value)
Multivariate odds 
ratio (95% ci)
Multivariate 
(p value)
Adenoviridae Positive 3 (1.2) 3 (1.2) 6 (1.2) 1.00 (0.67–1.50) 1.000 – –
Negative 254 (98.8) 254 (98.8) 508 (98.8)
Chlamydia trachomatisa Positive 1 (0.4) 10 (3.9) 11 (2.1) 10.36 (1.96–190.92) 0.026 10.64 (2.15–196.00) 0.025
Negative 256 (99.6) 247 (96.1) 503 (97.9)
Coagulase-negative 
Staphylococcus
Positive 15 (5.8) 11 (4.3) 26 (5.1) 0.72 (0.32–1.59) 0.423 – –
Negative 242 (94.2) 246 (95.7) 488 (94.9)
Haemophilus influenzae Positive 19 (7.4) 30 (11.7) 49 (9.5) 1.66 (0.91–3.07) 0.101 – –
Negative 238 (92.6) 227 (88.3) 465 (90.4)
Moraxella catarrhalis Positive 6 (2.3) 12 (4.7) 18 (3.5) 2.05 (0.78–5.96) 0.158 2.13 (0.81–6.20) 0.137
Negative 251 (97.7) 245 (95.3) 496 (96.5)
Staphylococcus aureus Positive 5 (1.9) 5 (1.9) 10 (1.9) 1.00 (0.28–3.64) 1.000 – –
Negative 252 (98.1) 252 (98.1) 504 (98.1)
Streptococcus pneumoniae Positive 18 (7.0) 16 (6.2) 34 (6.6) 0.88 (0.43–1.77) 0.723 – –
Negative 239 (93.0) 241 (93.8) 480 (93.4)
Any pathogen Positive 45 (17.5) 57 (22.2) 102 (19.8) 0.75 (0.48–1.15) 0.185 Not included
Negative 212 (82.4) 200 (77.8) 412 (80.2)
Different pathogen species 
in the same eye
0 212 (82.4) 200 (77.8) 412 (80.2) 1.21 (0.90–1.63) 0.207 Not included
1 28 (10.9) 35 (13.6) 63 (12.3)
>1 17 (6.6) 22 (8.6) 39 (7.6)
The relationship of those infections to trachoma has been tested with univariate logistic regression, and then stepwise removal of variables from multivariate regression model was 
used to determine the final multivariate regression model that provided the best fit for the data.
aData taken from the study by Butcher et al. (3).
Bold values indicate significant p-values < 0.05.
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bacterial genera were Corynebacterium (12.0% of total reads), 
Propionibacterium (6.2%), and Helicobacter (4.8%). In controls, 
the most dominant genera were Corynebacterium (13.9%), 
Paracoccus (5.2%), Propionibacterium (4.7%), and Neisseria 
(4.1%; Figure S1 in Supplementary Material). The genus level 
membership of the bacterial community varied between cases 
and controls. Of 21 genera represented by at least 1% of reads in 
specimens from those with active trachoma, 10 were not found in 
controls, including Helicobacter, Mesoplasma, Brachybacterium, 
and Haemophilus. Of 23 genera found in controls, 12 were not 
found in cases, including Neisseria, Prevotella, Rhodococcus, and 
Porphyromonas.
FigUre 2 | (a) First and second and (B) second and third principal components describing variation between the 16S sequences identified in Solomon Island 
children with and without active trachoma. Dark blue spots indicate controls. Light blue spots indicate cases. Red arrows show principal component loadings. PC, 
principal component; TF, trachomatous inflammation–follicular; TI, trachomatous inflammation—intense.
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PC analysis (Figure 2; Figure S2 in Supplementary Material) 
revealed that Corynebacterium (PC1), Paracoccus (PC2), 
Propionibacterium (PC2 and PC3), and Helicobacter (PC3) are 
major contributors to the variation in the conjunctival microbi-
omes of children in the Solomon Islands. While individual cases 
or controls have distinctive profiles dominated by these genera, 
the majority of cases and controls are indistinguishable (Figure 2) 
using the first three PCs (explaining 45% of total variation). We 
condensed PCs 1–20 into a single discriminant function, which 
explained 87% of variation in the data. In this analysis, the genus 
FigUre 3 | Discriminant analysis of the association of 20 combined principal 
components with active trachoma, showing a significant discrimination of 
phenotype groups (p = 0.000006). TF, trachomatous inflammation–follicular; 
TI, trachomatous inflammation—intense.
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level polymicrobial community structure is significantly different 
between cases and controls (logistic regression p = 0.0000062; 
Figure 3). That discriminant function was dominated by a num-
ber of genera such as Curvibacterium and Mesoplasma (Figure S3 
in Supplementary Material). Cross-validation to predict group 
membership using discriminant functions of between 10 and 
90 PCs had a low success rate (median 53.3% success; range: 
50.1–62.3%). This suggests that although differences do exist 
between the polymicrobial communities in cases and controls, 
they are too subtle and varied to be predictive of phenotype, at 
least when working with this number of specimens.
DiscUssiOn
Follicular conjunctivitis meeting criteria for the trachoma phe-
notype TF is highly prevalent in the Solomon Islands, but the 
prevalence of Ct infection is curiously low. Although Ct was the 
only pathogen to associate with TF in this study, the prevalence 
was much lower than may be expected of a population with 
this level of TF (3). Both S. pneumoniae and H. influenzae 
were detected at moderate prevalence in our population, while 
we found very few cases of Adenoviridae and M. catarrhalis 
infection. Comparator data from other populations are scarce, 
but it is clear that staphylococcal species were detected in the 
conjunctivae in the Solomon Islands at a substantially lower 
prevalence (7%) than in children in Tanzania (14.8% S. epi-
dermidis) (7), Sierra Leone (20% S. aureus and 29% coagulase-
negative Staphylococcus) (38), or The Gambia (post-MDA, 14.7% 
S. aureus) (11). By ddPCR testing for a number of bacteria and 
viruses that have previously been linked to TF, we can discount 
the possibility that any of them can account either singly or en 
masse for the high TF prevalence.
Through 16S amplicon sequencing and community profiling, 
we have shown that there is apparently no dominant bacterial 
genus associated with this disease. The dominant features of 
variation in conjunctival bacterial communities in Solomon 
Islands children (Corynebacterium and Propionibacterium) 
have consistently been identified in other studies. Other genera 
(e.g., Paracoccus, Helicobacter, Haemophilus) have not previously 
been identified as being important contributors to the conjunc-
tival microbiome in 16S studies, while some reported in other 
studies (e.g., Simonsiella, Pseudomonas) were not found in these 
specimens (18–21). Many studies have sequenced the V3–4 region 
of the 16S gene, whereas we targeted V1–3. V region choice has 
been shown to have an impact on the genera identified at other 
mucosal sites (39), and while no data have yet emerged on how 
this affects profiles from the eye, it is possible this could account 
for some of the differences. Consistent with previous studies (36), 
we found a background of genera that amplified in NTCs that 
also appeared in clinical specimens. The microbiological biomass 
at the conjunctiva is known to be very low, even compared with 
other nearby sites such as skin or oral mucosa (19). When true 
resident bacteria are scarce, 16S rRNA gene PCR readily amplifies 
reagent contaminants. We took stringent measures to exclude 
reagent contaminants, but this resulted in the removal of some 
important genera such as Staphylococcus and Streptococcus. 
Among the biggest contributors to between-conjunctiva vari-
ation were Corynebacterium and Propionibacterium, but these 
genera did not differentiate TF cases from controls (Figure 2). 
Previous investigations of the role of the conjunctival microbiome 
in ocular disease have also not shown significant differences. In 
The Gambia, there was an increased abundance of Haemophilus 
in cases of TF, compared to controls, although this difference was 
not significant (21). People with ocular manifestations of rosacea, 
Sjögren’s syndrome, and healthy controls did not have signifi-
cant differences in diversity or relative abundance of key phyla 
identified across all three groups (23). However, other disease 
associations have been identified. For example, the abundance of 
Corynebacterium and Streptococcus varied significantly between 
individuals with and without conjunctival scarring (21).
The microbiota of these children were heterogeneous and had 
subtle variations that appeared to reach significant association 
with TF when the full community structure was considered in 
comparative statistical models. It remains possible (though per-
haps unlikely) that a multitude of factors, operating at the level 
of single bacterial species, polymicrobial communities, or viral 
species, all contribute to the presentation of the phenotype. It is 
perhaps more likely that as yet unidentified viral or allergic causes 
could explain the prevalence of TF in the Solomon Islands.
There are some limitations to our study. First, although the 
ddPCR assays are based on the validated assays and appear to be 
accurate (Table S1 in Supplementary Material), they have not been 
formally evaluated in this format. Second, by not using mechani-
cal lysis in our extraction process, the absolute prevalence of some 
difficult-to-lyse Gram-positive genera (e.g., Staphylococcus) may 
have been underestimated. This would not impair the compari-
son of cases to controls, between which protocols were consist-
ent. Third, 16S amplicon sequencing of low biomass samples is 
known to result in amplification of reagent and environmental 
contaminants (36). This study focused on gross differences in 
community structure between those with and without disease, 
and these should be independent of contaminating reads. We also 
employed stringent quality control measures to ensure data were 
not confused by artifacts of the sequencing process.
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Given the current international commitment to trachoma 
elimination, further characterization of the role of non-Ct stimuli 
in TF is important. We might expect those with TF in the absence 
of Ct to be at lower risk of progression to TS and TT than those 
with repeated Ct infection and inflammation (40); however, 
such individuals have not been studied longitudinally to assess 
outcomes, and therefore, it is unclear how these cases should be 
managed. Furthermore, years after MDA has been administered, 
TF persists at levels above the threshold for elimination (> 5%) 
in communities where Ct infection is not readily detectable 
(41, 42). The public health risk of trachoma in these communities 
is also unclear.
Public health scenarios such as the one in the Solomon Islands 
will become increasingly common as trachoma elimination 
programmes reduce the global prevalence of Ct, and the positive 
predictive value of TF for ocular Ct infection declines as a result 
(43). MDA might be inappropriately delivered when clinical 
signs of trachoma are the only indicator used for programmatic 
decision-making. While MDA is effective for the treatment of 
trachoma (44), mass antibiotic exposure may increase macrolide 
resistance in non-chlamydial bacteria (45) and theoretically 
could make the population more susceptible to later infections 
by preventing accumulation of acquired immunity to Ct (46). 
Therefore, decisions to undertake such a program should be 
carefully considered. The case for using tests for Ct infection 
during trachoma surveys is strengthened by our data. The value 
of nucleic acid amplification tests for detecting non-chlamydial 
infection remains questionable, as multiple infectious agents 
might be important, and these may differ between populations.
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